Carregant...
RDNA-17. POWER DENSITY LOSS CAN BE USED TO DEFINED TUMOR TREATING FIELDS DOSE
Tumor Treating Fields (TTFields) are alternating electric at 200 kHz approved for the treatment of Glioblastoma Multiforme. Historically, TTFields dose has been quantified using the magnitude of the electric field, indicative of the force that the field applies on charged objects. However, when cons...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217537/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.931 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|